Complex Rules, Delayed NOCs Hurting Pharma Exports, Industry Demands Simpler Regulations At Pharmexcil Chintan Shivir In Indore

At the annual Pharmexcil Chintan Shivir 2026 in Indore, pharmaceutical exporters have been vocal about the need for simpler regulations and the streamlining of the process for obtaining No Objection Certificates (NOCs) to boost exports. Industry representatives highlighted that complex procedures and documentation requirements were negatively impacting overseas trade.

With over 100 participants from Madhya Pradesh, Delhi, and Gujarat, the meeting brought together stakeholders from the pharmaceutical industry, drug authorities, narcotics control, and foreign export regulatory bodies. While Indian medicines are in high demand abroad due to their quality, affordability, and superior service, the industry faces significant challenges due to extensive documentation and time-consuming export procedures.

Participants emphasized that the complicated documentation and new regulatory requirements often lead to unnecessary delays, causing Indian companies to lose out on export orders. They urged authorities to introduce practical, simplified regulations to sustain pharmaceutical export growth. The industry also advocated for relaxation in the rules governing NOCs, suggesting a uniform approval process for all medicines rather than category-specific regulations for different drugs.

Government officials shared information on existing schemes, facilities, procedural requirements, and potential business opportunities. Key attendees included MP Shankar Lalwani, director general K Udaya Bhanu, and other representatives from Madhya Pradesh, Delhi, and Gujarat. The discussions aimed at addressing regulatory hurdles and facilitating pharmaceutical exports through simpler procedures, allowing domestic manufacturers to capitalize on overseas demand.